Regencell Bioscience Holdings Ltd [NASDAQ: RGC] stock went on an upward path that rose over 235.48% on Thursday, amounting to a one-week price increase of more than 233.73%.
Over the last 12 months, RGC stock rose by 73.95%.
The market cap for the stock reached $183.34 million, with 13.01 million shares outstanding and 1.46 million shares in the current float. Compared to the average trading volume of 17.53K shares, RGC stock reached a trading volume of 22675412 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Regencell Bioscience Holdings Ltd [RGC]:
The Average True Range (ATR) for Regencell Bioscience Holdings Ltd is set at 1.12 The Price to Book ratio for the last quarter was 22.31, with the Price to Cash per share for the same quarter was set at 0.61.
RGC Stock Performance Analysis:
Regencell Bioscience Holdings Ltd [RGC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 233.73. With this latest performance, RGC shares gained by 277.24% in over the last four-week period, additionally plugging by 123.30% over the last 6 months – not to mention a rise of 73.95% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RGC stock in for the last two-week period is set at 91.57, with the RSI for the last a single of trading hit 94.88, and the three-weeks RSI is set at 87.62 for Regencell Bioscience Holdings Ltd [RGC]. The present Moving Average for the last 50 days of trading for this stock 4.56, while it was recorded at 6.11 for the last single week of trading, and 5.77 for the last 200 days.
Insight into Regencell Bioscience Holdings Ltd Fundamentals:
Regencell Bioscience Holdings Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 41.92 and a Current Ratio set at 41.92.
Regencell Bioscience Holdings Ltd [RGC] Institutonal Ownership Details
There are presently around $0.29%, or 2.64%% of RGC stock, in the hands of institutional investors. The top three institutional holders of RGC stocks are: UBS GROUP AG with ownership of 312.0 shares, which is approximately 0.0024%. BLACKROCK INC., holding 238.0 shares of the stock with an approximate value of $$800.0 in RGC stocks shares; and BLACKROCK INC., currently with $$44.0 in RGC stock with ownership which is approximately 0.0001%.
